Data / Research funding / North Carolina / Glycan Therapeutics Corporation
Glycan Therapeutics Corporation: 13 NIH awards ($15.3M), fiscal years 2021 to 2026
Glycan Therapeutics Corporation in Raleigh, NC is funded under 13 NIH awards ($15.3M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- KYG3DZSMH4R7
- State
- North Carolina
Awards
13 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Development of anticoagulant sulfated glycans | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,507,725 | August 16, 2023 | August 31, 2026 | PAGADALA, VIJAYAKANTH | reporter.nih.gov |
| Synthesis of the library of heparan sulfate hexasaccharide mimetics | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,405,945 | September 21, 2023 | September 14, 2027 | SU, GUOWEI | reporter.nih.gov |
| Development of heparan sulfate-based therapeutics to treat inflammatory diseases | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,387,583 | September 14, 2021 | July 31, 2026 | WANG, ZHANGJIE | reporter.nih.gov |
| Development of analytical methods for glycosaminoglycans from biological sources | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $1,977,542 | September 15, 2021 | August 31, 2025 | WANG, ZHANGJIE | reporter.nih.gov |
| Development of dekaparin to replace animal-sourced heparin | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,738,492 | August 1, 2017 | June 30, 2027 | PAGADALA, VIJAYAKANTH | reporter.nih.gov |
| Diverse Heparan Sulfate Oligosaccharide Libraries For Understanding and Therapeutically Manipulating Glycosaminoglycans | NIH | National Institute of General Medical Sciences | 2021 | $1,473,138 | June 15, 2021 | February 28, 2023 | PAGADALA, VIJAYAKANTH | reporter.nih.gov |
| Developing Heparan Sulfate Glycan Array | NIH | National Institute of General Medical Sciences | 2021 | $968,047 | September 1, 2017 | April 30, 2023 | SU, GUOWEI | reporter.nih.gov |
| Development of a sensitive method to measure heparan sulfate 6-O-endosulfatase | NIH | National Institute of General Medical Sciences | 2023 | $350,000 | February 1, 2023 | January 31, 2024 | SU, GUOWEI | reporter.nih.gov |
| Sulfated Carbohydrates for the Treatment of Periodontitis | NIH | National Institute of Dental & Craniofacial Research | 2023 | $347,537 | September 1, 2023 | August 31, 2025 | MIGUEZ, PATRICIA | reporter.nih.gov |
| Construction of chondroitin sulfate microarray | NIH | National Institute of General Medical Sciences | 2022 | $331,634 | May 1, 2022 | January 31, 2024 | SU, GUOWEI | reporter.nih.gov |
| National I-Corps: Development of synthetic heparin to protect liver graft from ischemia reperfusion injury during transplantation | NIH | National Cancer Institute | 2023 to 2024 | $306,076 | July 1, 2023 | June 30, 2024 | ARNOLD, KATELYN | reporter.nih.gov |
| Quantitative analysis of heparan sulfate using 13C-labeled standards | NIH | National Institute of General Medical Sciences | 2021 | $300,000 | September 15, 2021 | September 16, 2022 | PAGADALA, VIJAYAKANTH | reporter.nih.gov |
| Development of heparan sulfate-based therapeutics to treat inflammatory diseases | NIH | National Institute of General Medical Sciences | 2021 | $231,139 | September 14, 2021 | May 31, 2023 | ARNOLD, KATELYN | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 4 | $3,178,435 | 0 | $0 |
| 2024 | 5 | $4,431,012 | 0 | $0 |
| 2023 | 7 | $3,422,682 | 0 | $0 |
| 2022 | 2 | $1,320,405 | 0 | $0 |
| 2021 | 4 | $2,972,324 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) | RFA-OD-27-009 | NIH | 93.859 | November 10, 2026 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.859 | January 5, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.859 | January 5, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Medical Scientist Training Program (MSTP) (T32) | PAR-24-128 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T32) | PAR-24-235 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T34) | PAR-24-236 | NIH | 93.859 | January 25, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| National Centers for Cryo-electron Tomography (cryoET) (R24 -Clinical Trial Not Allowed) | PAR-26-138 | NIH | 93.859 | January 26, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed) | PAR-24-260 | NIH | 93.859 | January 27, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) | PAR-24-268 | NIH | 93.859 | January 27, 2027 | $500,000 | Same assistance listing 93.859 as 10 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.859 | April 5, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.859 | April 5, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.859 | May 7, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) | PA-24-191 | NIH | 93.859 | May 7, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | 93.859 | May 7, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | 93.859 | May 8, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) | PA-24-184 | NIH | 93.859 | May 8, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| IDeA Networks of Biomedical Research Excellence (INBRE) | PAR-26-026 | NIH | 93.859 | May 18, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Medical Scientist Training Program (MSTP) | PAR-27-002 | NIH | 93.859 | May 25, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Single Source: Resource Center for the Support for Research Excellence (SuRE) Program | PAR-28-025 | NIH | 93.859 | May 25, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
| Limited Competition: Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) | PAR-28-038 | NIH | 93.859 | May 25, 2027 | Not listed | Same assistance listing 93.859 as 10 awards here |
Topics of its NIH awards
- Digestive Diseases
- Liver Disease
- Translational Research
- Cancer
- Orphan Drug
- Rare Diseases
- Organ Transplantation
- Transplantation
- Hematology
- Dental/Oral and Craniofacial Disease
- Diabetes
- Infectious Diseases
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.